Loading...
OTCM
CBDL
Market cap375kUSD
Jul 09, Last price  
0.00USD
1D
0.00%
1Q
33.33%
IPO
-100.00%
Name

Cbd Life Sciences Inc

Chart & Performance

D1W1MN
OTCM:CBDL chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
34.47%
Rev. gr., 5y
-15.33%
Revenues
98k
-9.71%
00155,553122,78979,635225,89759,257160,241167,147108,89198,321
Net income
-49k
L-93.54%
-52,743-156,334-367,135-780,139-861,010-1,694,396-5,128,242-859,804-78,574-757,189-48,929
CFO
-139k
L-76.14%
-48,908-141,063-486,932-792,703-1,842,132-500,637-5,147,542-804,180-16,639-583,077-139,148

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

CBD Life Sciences Inc. specializes in formulating and distributing a broad array of organic items infused with cannabidiol. Their extensive range of natural CBD offerings includes hemp tinctures, topical massage oils, targeted recovery and pain relief balms, dietary aids to support anxiety and restful sleep, various consumable treats, and a dedicated collection of products for animal companions. The company's principal operations are conducted from Scottsdale, Arizona.
IPO date
Aug 12, 2013
Employees
4
Domiciled in
US
Incorporated in
US

Valuation

Title
in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT